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Abstract
Background: The successful implementation of cardiovascular disease (CVD) prevention guidelines relies heavily on
primary care physicians (PCPs) providing risk factor evaluation, intervention and patient education. The aim of this
study was to ascertain the degree of awareness and implementation of the Spanish adaptation of the European
guidelines on CVD prevention in clinical practice (CEIPC guidelines) among PCPs.
Methods: A cross-sectional survey of PCPs was conducted in Spain between January and June 2011. A random
sample of 1,390 PCPs was obtained and stratified by region. Data were collected by means of a self-administered
questionnaire.
Results: More than half (58%) the physicians were aware of and knew the recommendations, and 62% of those
claimed to use them in clinical practice, with general physicians (without any specialist accreditation) being less
likely to so than family doctors. Most PCPs (60%) did not assess cardiovascular risk, with the limited time available in
the surgery being cited as the greatest barrier by 81%. The main reason to be sceptical about recommendations,
reported by 71% of physicians, was that there are too many guidelines. Almost half the doctors cited the lack of
training and skills as the greatest barrier to the implementation of lifestyle and behavioural change
recommendations.
Conclusions: Most PCPs were aware of the Spanish adaptation of the European guidelines on CVD prevention
(CEIPC guidelines) and knew their content. However, only one third of PCPs used the guidelines in clinical practice
and less than half CVD risk assessment tools.
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Background
Reducing levels of modifiable cardiovascular risk factors
is a key goal in cardiovascular disease (CVD) prevention,
and management guidelines are the prime means by
which scientific societies aim to achieve this goal. CVD
prevention guidelines have been published by a consor-
tium of European societies which aim to promote more
intensive cardiovascular risk reduction strategies by
encouraging the assessment of an individual’s total CVD
risk rather than focusing on individual risk factors [1]. In
addition, European guidelines clearly stated the import-
ance of developing national guidance on CVD preven-
tion to suit political, economic, social, and medical
circumstances at country level. The Spanish Committee
for CVD Prevention (Comité Español Interdisciplinario
para la Prevención Cardiovascular-CEIPC) was created
in June 2000, during the European Forum on Prevention
of Coronary Heart Disease in Clinical Practice Regional
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Follow-up Meeting (Southern Europe). The CEIPC is an
official alliance of 15 professional scientific societies sup-
ported by the Spanish Ministry of Health. Two national
adaptations of the European guidelines for CVD prevention
have been developed by CEIPC, the first in 2004 [2] and
the second in 2008 [3]. These adaptations have introduced
some changes with regard to treatment targets and imple-
mentation in order to reflect different social and medical
circumstances. Both documents have been published in 8
national journals and disseminated through webpages,
scientific meetings and training seminars. There is evidence
that guidelines adherence remains low and risk assessment
tools are not always used as intended [4,5].
The adoption of guidelines in clinical practice has been
related to physician awareness/agreement, self-efficacy, out-
come expectancy and practice habits/routines, in addition
to patient- and system-related factors [6]. Furthermore, the
successful implementation of CVD prevention guidelines
relies heavily on primary care physicians (PCPs) providing
risk factor evaluation, intervention and patient education.
In Spain, it is mandatory for PCPs to complete specialty
training in family medicine; however, there are still
general doctors working as PCPs without any specialist
accreditation.
Although several studies analysed implementation
issues in Europe, most were small and non-representative
of the general population of doctors working in primary
care in each country participating in the survey [7,8].
Moreover, the implementation of local adaptations of
European guidelines for CVD prevention has not been
formally assessed to date. The aim of this study was to
assess the use of the Spanish adaptation of the European
guidelines on CVD prevention in clinical practice (CEIPC
guidelines) among PCPs, and ascertain whether awareness
of and barriers to adoption of the CEIPC guidelines varied
according to physician characteristics (age, sex, medical
specialty) and work setting.
Methods
Design and subjects
A cross-sectional survey on awareness of and barriers to
CVD prevention guidelines was conducted among PCPs
in Spain between January and June 2011. A random
sample, stratified by all the seventeen regions of Spain
plus the cities of Ceuta and Melilla, was obtained from
the list of primary care physicians working in Spain
available at the website of the Spanish Ministry of Health
[9]. Assuming an estimated true proportion of 0.5, a max-
imum acceptable difference of 10% and an α error of 0.05,
the required sample size calculated was 1,457 PCPs. The
number of physicians selected for each stratum was propor-
tional to their distribution in the database. Consecutive ran-
dom sampling (with replacement of those who declined to
participate when contacted by phone) continued until the
target number of physicians in each region agreeing to be
interviewed was reached. The questionnaire was sent to
those who agree to participate.
Written informed consent was obtained from each
participant before the questionnaire was answered.
Confidentiality was maintained by data coding to elimin-
ate possible identification of personal information.
Data collection
Focus groups were used to generate and refine items of
the questionnaire used in the survey. The questionnaire
was tested for comprehension and usefulness in a pilot
study on a small sample of GPs. Data were collected by
means of a self-administered questionnaire delivered by
mail, with questions regarding awareness of the CEIPC
guidelines, risk assessment and barriers to the imple-
mentation of recommendations. In addition, information
on physician demographic characteristics, medical specialty
and work setting was collected. The questionnaire
comprised 24 questions, most of which prompted a
choice from a list of options, allowing for open answers
when appropriate.
Statistical analyses
Means and standard deviations and percentages and
95% confidence intervals were used to describe the con-
tinuous and categorical variables. Comparisons by age
(<50 years versus >49 years), sex, setting (rural, suburban
versus urban), medical specialty (family medicine versus
general medicine), and working or not at an academic
teaching centre were made using the chi-square test.
A p value less than 0.05 was considered statistically
significant. All statistical analyses were made with STATA
statistical software (Version 9.2).
Ethical approval was not required in Spain at the time
the study was carried out.
Results
Sixty-seven physicians were excluded from the analysis
owing to some missing data on major variables. Thus,
the analysis was based on the remaining 1,390 PCPs
(56% men, 44% women). The response rate was 33.5%,
without significant differences among regions. Characteris-
tics of the survey respondents are provided in Table 1.
The results of PCP awareness of the CEIPC guidelines
are shown in Table 2. More than half the physicians
(58%) were aware of and knew the CEIPC guidelines. Of
these, 62% used them in clinical practice (36% of all phy-
sicians) and 38% stated they were employing a different
set of local or international guidelines. Approximately a
quarter of physicians (26%) were aware of the CEIPC
guidelines but did not know their recommendations, and
16% had never heard of them. Physician awareness and use
of CEIPC guidelines in clinical practice differed according
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to physician specialty, with family doctors being more
likely than general doctors to be aware of and use the
recommendations (60.1% versus 53.4%, p < 0.001, and
64.21% versus 54.82%, p < 0.03, respectively; data not
shown in the table). No differences were observed for age,
sex, setting, or working at an academic teaching
centre.
Regarding total cardiovascular risk estimation, Figure 1
shows the % of PCPs that calculated the risk in 100%,
80%, 60%, 40%, 20% of the patients or never. We can see
that 40% of participants calculated the risk in 80-100%
of their patients with at least one risk factor, while 36%
of respondents calculated it in 40% or less of their
patients. Assessment of CVD risk differed according to
physician age (46% of physicians younger than 50 years
calculated the risk in 80-100% of patients versus 33% of
physicians older than 49 years, p < 0.001), specialty (43%
of family doctors calculated the risk in 80-100% of pa-
tients versus 23% of general physicians, p < 0.001) and
setting (39% of urban physicians calculated the risk in
80-100% of their patients versus 35% of rural physicians,
p < 0.001). When PCPs were asked as to the main bar-
rier to assessing cardiovascular risk, the majority of
respondents (81%) cited limited surgery time as the
most significant (Figure 2). Other barriers mentioned
by participants were lack of computer-based risk charts
(18%) and charts not being based on Spanish data (16%).
When questioned on reasons for being sceptical
about the recommendations, 71% of physicians reported
that there are too many guidelines, 50% that targets
for individual risk factors are unrealistic, and 36%
that guidelines are influenced by the pharmaceutical
industry (Figure 3).
The lack of training and skills was the greatest barrier to
the implementation of lifestyle and behavioural change
recommendations for 48% of participants. Other barriers
commonly cited were the perception that lifestyle advice
is not effective in changing patient behaviour (41%), and
limited dedication time of nursing staff (38%) (Figure 4).
When PCPs were asked about the reasons why
patients sometimes fail to reach the recommended targets
for cardiovascular risk factors, 82% stated that patients
were the greatest barrier since they do not perceive
themselves to be patients at risk, and 63% stated that
patients have various comorbidities and treatments
(data not shown in the figure).
Discussion
Our results reflect a wide dissemination of the CEIPC
guidelines: more than three quarters of Spanish doctors
had heard of the Spanish adaptation of the European
guidelines on CVD prevention in clinical practice
(CEIPC guidelines) and almost 60% totally or partially
knew the contents of the guideline. However, only 36%
were using the CEIPC guidelines in clinical practice,
with family doctors being more likely to use them than
general physicians, as the latter are still working as PCPs
without any specialist accreditation. An unexpected result
was that PCPs working in academic teaching centres were
Table 1 Characteristics of participating physicians
(n = 1,390)
N mean (SD)
Age (years) 1390 50 (7.24)
Time in practice (years) 1316 21.61 (8.17)
% (95% CI)
Sex
Male 759 55.65 (52.96-58.30)
Female 605 44.35 (41.69-47.03)
Specialty
Family medicine 1041 76.65 (74.31-78.88)
General medicine 299 22.02(19.83-24.31)
Others 18 1.32 (0.78-2.08)
Setting
Urban 961 70.82 (68.32-73.23)
Suburban 254 18.72 (16.67-20.90)
Rural 142 10.46 (8.89-12.22)
Academic Teaching Centre 594 45.07 (42.36-47.80)
Table 2 Physician awareness of the CEIPC guidelines
(n = 1,390)
n %
Were aware and had knowledge 801 57.6
Used them in clinical practice (n = 781) 486 62.2
Did not use them in clinical practice (n = 781) 295 37.8
Were aware of but did not know recommendations 354 25.5
Never heard of CEIPC guidelines 226 16.3
Figure 1 Percentage of patients in whom cardiovascular risk
was calculated.
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not doing better in terms of using CEIPC guidelines that
those not affiliated to this kind of centres. This result
could be explained because CEIPC guidelines were widely
disseminated to all kind of centers, regardless their
academic characteristics.
A survey of 1,382 physicians from Croatia [10] showed
that 56.9% were using the European CVD prevention
guidelines in clinical practice; PCPs were found to be
more likely to use their own experience, while internists
and cardiologists were more likely to use the European
guidelines. Another study of 500 physicians from the
United States [5] found that, despite 90-100% of awareness
of CVD guidelines among physicians, only 50-60% incorpo-
rated them into clinical practice. A survey conducted in
six European countries among 220 cardiologists and
PCPs reported that physicians’ use of CVD prevention
guidelines in different European countries varied between
60% and 97% [7].
Figure 2 Barriers to the assessment of cardiovascular risk.
Figure 3 Most common reasons to be sceptical about guidelines recommendations.
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A discouraging observation stemming from this study
is that less than half the physicians (40%) calculated
overall cardiovascular risk in more than 80% of their
patients with at least one risk factor. Similarly, the
Reassessing European Attitudes about Cardiovascular
Treatment (REACT) study [8], which examined attitudes
to and implementation of coronary heart disease and
lipid treatment among 754 European PCPs, showed that
43% of physicians rarely or never used risk calculator
charts, 43% sometimes referred to them, but only 13%
reported that this was always the case. A further survey
showed that 62% of physicians used a subjective assessment
of risk factors rather than a specific risk calculator, with car-
diologists being more likely than PCPs to use a subjective
assessment [7]. A recent study done in Canada showed that
74% primary care physicians performed CV risk assessment
in eligible patients annually [11]. Interestingly, we found
that young, urban and family doctors more often assessed
the risk than old, rural and general physicians.
Regarding the barriers to cardiovascular risk assessment,
the European survey of physicians’ practices in the control
of cardiovascular risks factors (EURIKA study) [12] found
that 60% of physicians reported that they did not calculate
total cardiovascular risk owing to time constraints, a finding
similar to that of our study. A further significant barrier
reported in the EURIKA study was that risk assessment is
of little use and, moreover the participants did not know
how to use it. In contrast, in addition to time constraints,
we found the most important barriers to be the lack of
computer-based risk charts, charts not being based on
Spanish data, major risk factors not being included in risk
charts (also reported in the EURIKA study) and each risk
factor being addressed separately. Doctors probably do not
understand how integrated cardiovascular risk management
guidelines still promote the management of raised blood
pressure and blood cholesterol. It has been mentioned that
it is time for terms such as hypertension and hypercholes-
terolaemia to be removed from our vocabulary, and the
next generation of clinicians should treat risk and not
risk factors [13].
Although many physicians in our survey suggested
that the patient himself was a significant impediment to
achieving CVD targets, this may reflect the perceived
difficulty in adherence to lifestyle factors and pharmaco-
logical treatments. Other studies [5,8] have also shown
patient compliance to be the most common barrier to
the implementation of cardiovascular risk reduction. A
study designed to assess understanding of CV risk by
patients recently diagnosed with diabetes mellitus and/
or metabolic syndrome treated at primary care centres
showed that participants had poor awareness of their
CV risk and almost half thought they had good or
excellent health [14].
The most important reason reported by physicians for
being sceptical about recommendations was the exist-
ence of too many guidelines, a result similar to that
found by researchers of the EURIKA study [12]. PCPs
may be overwhelmed by the amount of literature they
receive and the existence of multiple guidelines for the
same topic, which renders it difficult for them to
Figure 4 Barriers to the implementation of lifestyle and behavioral change recommendations.
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determine which one is/are the best to use in clinical
practice. Another important reason reported was that
targets for individual risk factors are not realistic in
many patients, a fact also mentioned by physicians of
the EURIKA study [12]. In clinical practice sometimes it
is not easy to implement recommendations of guidelines
and achieve specific targets because patients may have
multiple comorbidities, being a real challenge to appro-
priately manage all the conditions.
Almost half the PCPs in our study felt they had insuf-
ficient personal training and probably needed further
experience and skills to improve the implementation of
lifestyle and behavioural change recommendations in
their patients. In addition, 41% felt sceptical about the
effectiveness of lifestyle advice. This finding is similar
to that of a survey of 2,082 PCPs carried out in eleven
European countries [15] which reported that 58.2%
and 52.8% of physicians had the perception that they
were minimally effective in helping patients achieve or
maintain normal weight or in helping patients practise
regular physical exercise, respectively. Another major
barrier to the implementation of lifestyle and behavioural
change recommendations reported in our study was the
limited dedication time of nursing staff. In another study
[7] 46% of physicians recommended increasing the
number of nurses trained in prevention as a practical
means of improving guideline implementation. It has
previously been suggested that clinical practice may be
improved by allowing nurses to discuss more thoroughly
with patients the importance of lifestyle changes in
reducing the risk of CVD [16,17].
One limitation of this study regards low participation rate
and sample representativeness. PCPs who responded to the
survey presumably were more interested in CVD preven-
tion and aware of the CEIPC guidelines, although the
potential biases are unpredictable. There is the potential
that nonresponding physicians have a different knowledge
base, awareness, practice patterns, and perceptions than
our responding physicians. However, the large sample size
and the similar regional distribution of nonresponders help
mitigate some of this concern. In addition, this study was
largely based on self-reporting by PCPs, which might not
accurately reflect the way they actually practise.
Another limitation of this study is that we lack informa-
tion on reliability and validity of the questionnaire used.
Whether this has any impact on the results remains to be
evaluated. However, we did perform a pilot study in order
to test for comprehension and usefulness.
Mean age of respondents (50 years) and mean time in
practice (22 years) reflect a population relatively old,
which reflects a population of doctors with high experi-
ence in clinical practice, and this might have influenced
the results of the study. Despite such limitations, we are
reasonably confident of the generalizability of our results,
as the sample of doctors was large, randomly selected, and
represented all the regions of Spain.
Conclusions
Most Spanish PCPs were aware of the Spanish adaptation
of the European guidelines on CVD prevention in clinical
practice (CEIPC guidelines) and more than half knew the
content of the guidelines. However, the implementation of
the guidelines can still improve, given that only one third
of PCPs used them in clinical practice and less than half
use CVD risk assessment tools. It is important to register
relevant information in electronic medical records,
rendering automated calculation of risk and the use of
on-screen reminders possible. Strategies to overcome
organisational constraints such as consultation time, and
greater involvement of nurses and other health care
professionals should be developed.
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